ThreeD Capital Expands Portfolio with Sariel Diagnostics Deal
Company Announcements

ThreeD Capital Expands Portfolio with Sariel Diagnostics Deal

Story Highlights

ThreeD Capital (TSE:IDK) has released an update.

ThreeD Capital Inc., a Canadian venture capital firm, has announced a Securities Purchase Agreement with Sariel Diagnostics Corp. to acquire 3.2 million shares, further expanding its portfolio in junior resources and disruptive technologies. The transaction is contingent on approval from the Canadian Securities Exchange and involves the issuance of ThreeD shares at a deemed value.

For further insights into TSE:IDK stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskThreeD Capital Reports Latest Unaudited NAV
TipRanks Canadian Auto-Generated NewsdeskThreeD Capital Strengthens Investor Relations with PHK
TipRanks Canadian Auto-Generated NewsdeskThreeD Capital Reports Unaudited NAV of $0.86
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App